Literature DB >> 1219186

[Quantitative determination and phenotyping of ceruloplasmin in morbus Wilson (author's transl)].

H W Goedde, H G Benkmann, J Lange, H Harders.   

Abstract

Sera of 17 patients with Wilson's disease and of 48 relatives were investigated as to a possible correlation between ceruloplasmin phenotypes and Wilson's disease. The control group included 727 healthy subjects. The results of the quantitative determination of ceruloplasmin confirmed the overlapping in the groups of so-called heterozygotes and controls known from the literature. The ceruloplasmin phenotypes in starch gel electrophoresis we observed were of the most common phenotype Cp BB in the patients as well as in the controls. Therefore, patients with Wilson's disease also show the normal Cp-phenotypes.

Entities:  

Mesh:

Year:  1975        PMID: 1219186     DOI: 10.1007/bf01468706

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  30 in total

1.  The heterogeneity of the copper-containing protein of human plasma, ceruloplasmin.

Authors:  S Z HIRSCHMAN; A G MORELL; I H SCHEINBERG
Journal:  Ann N Y Acad Sci       Date:  1961-11-02       Impact factor: 5.691

2.  Wilson's disease and the concentration of caeruloplasmin in serum.

Authors:  I H SCHEINBERG; I STERNLIEB
Journal:  Lancet       Date:  1963-06-29       Impact factor: 79.321

3.  Starch gel electrophoresis in a discontinous system of buffers.

Authors:  M D POULIK
Journal:  Nature       Date:  1957-12-28       Impact factor: 49.962

4.  The molecular structure of human ceruloplasmin: a proposed model.

Authors:  M H Shokeir
Journal:  Clin Biochem       Date:  1973-03       Impact factor: 3.281

5.  A genetic study of Wilson's disease: evidence for heterogeneity.

Authors:  D W Cox; F C Fraser; A Sass-Kortsak
Journal:  Am J Hum Genet       Date:  1972-11       Impact factor: 11.025

6.  On the population genetics of the ceruloplasmin polymorphism.

Authors:  G Kellermann; H Walter
Journal:  Humangenetik       Date:  1972

7.  Long-term therapy of Wilson's disease.

Authors:  A Deiss; R E Lynch; G R Lee; G E Cartwright
Journal:  Ann Intern Med       Date:  1971-07       Impact factor: 25.391

8.  Ceruloplasmin in Wilson's disease.

Authors:  N A Holtzman; M A Naughton; F L Iber; B M Gaumnitz
Journal:  J Clin Invest       Date:  1967-06       Impact factor: 14.808

9.  Lysosomal defect of hepatic copper excretion in Wilson's disease (hepatolenticular degeneration).

Authors:  I Sternlieb; C J Van den Hamer; A G Morell; S Alpert; G Gregoriadis; I H Scheinberg
Journal:  Gastroenterology       Date:  1973-01       Impact factor: 22.682

10.  Genetic polymorphism of the third component of human complement (C'3).

Authors:  C A Alper; R P Propp
Journal:  J Clin Invest       Date:  1968-09       Impact factor: 14.808

View more
  2 in total

1.  [Insufficiency of the exocrine pancreas in Wilson's disease (author's transl)].

Authors:  P Osswald; K H Niessen
Journal:  Klin Wochenschr       Date:  1976-09-01

2.  Studies on the polymorphism of C3, Tf and Bg in Down's syndrome and other diseases.

Authors:  D P Agarwal; L M Srivastava; H G Benkmann; H W Goedde
Journal:  Humangenetik       Date:  1975-08-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.